Jump to content
Knowledge Hub

News Archive

EMA - Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 December 2022

21st December 2022

EMA - Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 December 2022

Read More+

EMA - Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 November - 1 December 2022

21st December 2022

EMA - Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 November - 1 December 2022

Read More+

EMA - Recommendation Paper on Decentralised Elements in Clinical Trials

21st December 2022

The European Commission (EC), the Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) have published recommendations that aim to facilitate the conduct of decentralised clinical trials (DCTs) while safeguarding the rights and well-being of participants as well as the robustness and reliability of the data collected. This is an outcome of their joint initiative to Accelerate Clinical Trials in the European Union (ACT EU).

Read More+

MHRA - Business Impact Target

21st December 2022

MHRA assesses its regulatory impact on businesses. Non-qualifying Regulatory Provisions (NQRP) summary 2021-22 available.

Read More+

MHRA Board Meetings in 2023

21st December 2022

MHRA Board Meetings in 2023

Read More+

MHRA to receive nearly £1m BEIS funding to unlock digital, data and scientific regulatory innovation

21st December 2022

MHRA to receive nearly £1m BEIS funding to unlock digital, data and scientific regulatory innovation

Read More+

TransCelerate - Considerations for Data Relevance and Reliability

21st December 2022

Does your organisation provide or utilise Real-World Evidence / Real-World Data for regulatory-grade research? TransCelerate Biopharma Inc.’s Real-World Data (RWD) Audit Readiness Initiative wants to hear from you!

Read More+

EMA - public consultation - Reflection paper on the application of Article 40(5) of Regulation (EU) 2019/6 for certain categories of variations.

15th December 2022

This draft reflection paper provides potential criteria to support the demonstration of a reduction in the antimicrobial or antiparasitic resistance, or an improvement of the benefit-risk balance. Comments should be provided using this template and sent to vet-guidelines@ema.europa.eu by 28 February 2023.

Read More+

MHRA Blog - When is a clinical trial halt not a clinical trial halt?

15th December 2022

As the regulator, the safety of those volunteering to participate in clinical trials is our first priority, and our oversight of trial conduct is informed by trial sponsors efficiently notifying us of safety issues during the conduct of their trial. This blog aims to clarify regulatory expectations for notification of temporary halts via a substantial amendment and requests to restart a trial after a temporary halt has been notified.

Read More+

EDQM - Contribute to shaping the future EDQM strategy – Stakeholder survey

30th November 2022

EDQM - Contribute to shaping the future EDQM strategy – Stakeholder survey

Read More+
« Previous | Page 35 of 92 | Next »

Share

Virtual Event Platform